Dermatologists Treat Children’s Psoriasis Differently Than Adult Psoriasis– Medications and Procedures Explained

Psoriasis is a life-long skin disease that often begins during childhood and affects about 3.5% of the population.1 It is associated with the immune system and causes skin cells to reproduce rapidly. This results in an over-accumulation of skin cells on the surface, which can form painful, red itchy lesions.

In greater than 33% of patients, the initial presentation of psoriasis occurs before a person turns 20.2-5 It is estimated that 10% of patients develop psoriasis before the age of 10.6

In some cases, children’s psoriasis can differ in presentation than adult psoriasis. For infants, psoriasis tends to appear as diaper rash. Some children may develop a patch of psoriasis where skin has been injured, or after a bout of bacterial infections such as “Strep throat.” Often times, children’s psoriasis presents itself on highly visible areas of skin, such as the face and scalp.

For children and young adults that are in the budding stages of developing their own personal “sense of self”, this skin condition can be very emotionally distressing and lead to feelings of anxiety and embarrassment.

This article will look at the way psoriasis affects children, triggers for flare-ups, and the recommended treatment options that are currently available.

Types of Psoriasis Seen In Children

Plaque Psoriasis: This is the most common type of psoriasis that affects children. It’s characterized by raised, inflamed, red lesions on the skin, covered by silvery white scales. Plaque psoriasis routinely affects the scalp, which in some cases, can lead to temporary hair loss.2,8 Plaque psoriasis can also affect the face, as well as outer and inner sides of the knees and elbows.2,9

Psoriatic Diaper Rash: This is next most common form of psoriasis in children. Psoriatic diaper rash features a bright red, well-demarcated, glazed, diaper rash that may be followed by the appearance of small psoriasis-like lesions.2 Although the rashes typically appear in the groin area, they can also spread elsewhere on the body. This type of diaper rash can be differentiated from irritant diaper dermatitis by its unique presentation and poor response to conventional treatment for diaper dermatitis.2

Guttate Psoriasis: This form of psoriasis appears as small, red, individual spots on the skin and affects the skin on the trunk, abdomen, and back.8 These spots are not usually as thick as plaque lesions and can flare up quite suddenly.

Pustular and erythrodermic psoriasis are less frequently seen in children than adults.2,9

Pustular Psoriasis: This type of psoriasis is characterized by the appearance of white, puss-filled blisters that are surrounded by red skin.

Erythrodermic Psoriasis: This type of psoriasis is characterized by the appearance of fiery red and inflamed patches of skin that cover most of the body. The shedding of scales often occurs in sheets, rather than smaller flakes. The reddening and shedding of the skin are often accompanied by intense itching and pain.

Factors that can Induce/Aggravate Psoriasis

Psoriasis in children and adults is a complicated disease. The exact causes of psoriasis are not well understood, but are known to be multifactorial, having both genetic and environmental influences.9

A variety of factors, such as upper respiratory infection, emotional stress, skin injury, and drugs, can trigger flare-ups and worsen psoriasis in children.2,6,8,13 In childhood, certain infections such as Strep throat can trigger psoriasis flare-ups.2,7,8 The frequency of sore throats and skin trauma leading to the worsening of psoriasis is greater in children than adults with psoriasis.5,13 The appearance of new lesions in times of emotional stress is also more common in pediatric patients.13 Injury or irritation of normal skin can induce new psoriatic lesions, known as the Koebner phenomenon.

71% of children with psoriasis have a positive history for psoriasis in a first degree relative.7



When treating children with psoriasis, it is important both children and parents to be fully educated about the nature of the disease. It must be made clear that psoriasis is a chronic skin disorder without a permanent cure and, therefore, the goal of treatment is to establish disease control and prolong periods between flares.23

Topical Medications
Topical medications are the first choice therapy for children with psoriasis. Systemic agents are used to treat more severe cases.

Topical corticosteroids are the first choice treatment of childhood psoriasis. Corticosteroids have anti-inflammatory and antiproliferative (helps stop spreading) properties that reduce redness, scaling, and itching.5,9 Side-effects of topical steroids include skin degeneration, marks on the skin similar to stretch marks, broken blood vessels and acne-like eruptions

Coal Tar
Coal tar is a by-product of oil production that has been found to be an effective ingredient in skin care preparations. It works by slowing the rapid growth of skin cells, reducing inflammation and itching and scaling. The use of coal tar is limited by its strong odor and ability to stain.  Coal tar is less irritating than calcipotriene and anthralin on the face and skin folds, sites commonly affected in children.25

Anthralin (dithranol) is a medication that works by slowing down the growth of skin cells. It also has potent anti-inflammatory properties..5 Anthralin’s use is limited due to its tendency to stain skin and clothing and irritate healthy skin. It is not recommended for application on the face, in skin folds and genitalia, and should not be used in erythrodermic or pustular psoriasis.9 In an open study of 58 children ages 5-10 years, remission was achieved in 47 patients (81%) using dithranol.28

Calcipotriene (calcipotriol) is considered to be a successful and safe treatment for children with mild to moderate plaque psoriasis that affects more than 30% of the body surface.2Calcipotriene is a derivative of Vitamin D, and works by controlling the rapid growth of skin cells. It is non-staining and odorless.9 Potential side-effects include skin tenderness and irritation.8

Topical Calcineurin Inhibitors
Tacrolimus and pimecrolimus are non-steroidal medications that work by blocking the immune system’s inflammatory process, so they reduce inflammation of the affected skin as well the itch and rash associated with psoriasis.5 They are particularly useful for treating pediatric psoriasis in areas where atrophy is a risk, such as the face, areas where skin rubs together, and the groin.9

Salicylic Acid
Salicylic acid is recommended for use on thick localized plaques.2,5 However, salicylic acid should be avoided in infants and children less than 6 years of age, or otherwise used with caution, as there is a risk of salicylate intoxication.2,5

Phototherapy is extensively used in adults and is a treatment option for children with widespread plaques.2 Narrowband UVB (NB-UVB) phototherapy may be combined with topical therapies to enhance the effectiveness of both treatments and to reduce the carcinogenic risks.2,5 Psoralen + UVA (PUVA) therapy is not generally recommended in young children, but may be used in adolescents with caution.5,9,25 NB-UVB is considered the first-line phototherapy because it is as effective as PUVA, more convenient, and less carcinogenic.5,29

Systemic Medications

Acitretin, a retinoid, is an effective treatment for severe plaque, pustular, and erythrodermic psoriasis in adolescents.5 It can be used as single therapy or in combination with topical medications and NB-UVB phototherapy. Side-effects includecheilitis, itchiness, and hair loss.2

Acitretin should be used with caution in girls of childbearing age and must be accompanied by oral contraceptive therapy, as well as counseling, to avoid pregnancy during and 3 years after the completion of treatment.30 Serious birth-defects may be a possible side effect of taking this drug. Long-term use can lead to premature epiphyseal closure (discontinued growth of long bones) and radiologic bone evaluations may be required.30

Methotrexate, is rarely used in children and reserved for severe psoriasis unresponsive to other treatments.30,31 This medication treats psoriasis by slowing the growth of skin cells to stop scales from forming. Side-effects include nausea, headache and gastrointestinal upset, which can be minimized with folic acid supplements.9

Cyclosporine is an immunosuppressant that can be used to treat extremely severe cases of pediatric psoriasis. Close monitoring by  a physician is necessary due to major risks of hypertension and kidney dysfunction.

Antibiotics may be prescribed to treat recurring or flares of guttate psoriasis, caused by strep bacteria infections.30

A chronic, visible condition like psoriasis can have a significant impact on children’s psychosocial development.24 Through school years and adolescence, children should be given substantial family and professional support to cope with the psychological and social consequences of psoriasis, particularly the negative reactions of other children.25 In order to correctly diagnose and treat children and adolescents, it is important to recognize the different presentations of the disease. Children with psoriasis, including their parents and caregivers, should be educated about the natural history of the disease and the factors responsible for flare-ups, as well as receive support and counseling to help cope with their condition.


1. Kurd SK, Gelfand JM. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 2009 Feb;60(2):218-24.

2.Benoit S, Hamm H. Childhood psoriasis. Clin Dermatol 2007 Nov-Dec; 25(6):555-62.

3. Romiti R, Maragno L, Arnone M, et al. [Psoriasis in childhood and adolescence]

. An Bras Dermatol 2009 Jan-Feb;84(1):9-20.

4. Rogers M. Childhood psoriasis. Curr Opin Pediatr 2002 Aug;14(4):404-9.

5. Cordoro KM. Management of childhood psoriasis. Adv Dermatol 2008; 24:125-69.

6. Farber EM, Jacobs AH. Infantile psoriasis. Am J Dis Child 1977 Nov; 131(11):1266-9.

7. Morris A, Rogers M, Fischer G, et al. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001 May-Jun;18(3):188-98.

8. Silverberg NB. Pediatric psoriasis: an update. Ther Clin Risk Manag 2009; 5:849-56.

9. Leman J, Burden D. Psoriasis in children: a guide to its diagnosis and management. Paediatr Drugs 2001;3(9):673-80.

10. Henseler T, Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985 Sep;13(3):450-6.

11. Nair RP, Stuart PE, Nistor I, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 2006 May;78(5):827-51.

12. Valdimarsson H. The genetic basis of psoriasis. Clin Dermatol 2007 Nov-Dec;25(6):563-7.

13. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000 May-Jun;17(3):174-8.

14. O’Brien M, Koo J. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 2006 May;5(5):426-32.

15. Bernhard JD. Clinical pearl: Auspitz sign in psoriasis scale. J Am Acad Dermatol 1997 Apr;36(4):621.

16. Al-Mutairi N, Manchanda Y, Nour-Eldin O. Nail changes in childhood psoriasis: a study from Kuwait. Pediatr Dermatol 2007 Jan-Feb;24(1):7-10.

17. Kumar B, Jain R, Sandhu K, et al. Epidemiology of childhood psoriasis: a study of 419 patients from northern India. Int J Dermatol 2004 Sep;43(9):654-8.

18. Lerner MR, Lerner AB. Congenital psoriasis: report of three cases. Arch Dermatol 1972 Apr;105(4):598-601.

19. Atherton DJ, Kahana M, Russell-Jones R. Naevoid psoriasis. Br J Dermatol 1989 Jun;120(6):837-41.

20. Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J Pediatr 1988 Dec;113(6):1037-9.

21. Howard R, Tsuchiya A. Adult skin disease in the pediatric patient. Dermatol Clin 1998 Jul;16(3):593-608.

22. Liao PB, Rubinson R, Howard R, et al. Annular pustular psoriasis–most common form of pustular psoriasis in children: report of three cases and review of the literature. Pediatr Dermatol 2002 Jan-Feb;19(1):19-25.

23. Kragballe K, Wildfang IL. Calcipotriol (MC 903), a novel vitamin D3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990;282(3):164-7.

24. Beattie PE, Lewis-Jones MS. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006 Jul;155(1):145-51.

25. Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999 Sep;24(5):341-5.

26. Zivkovich AH, Feldman SR. Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol 2009 Jun;8(6):570-2.

27. Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work? Clin Dermatol 2006 May-Jun;24(3):229-30.

28. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol 1994 Nov;33(11):808-10.

29. Van Weelden H, Baart de la Faille H, Young E, et al. Comparison of narrowband UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol 1990;70(3):212-5.

30. Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Lett 2008 May;13(4):1-3.

31. de Jager ME, de Jong EM, van de Kerkhof PC, et al. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol 2010 Jun;62(6):1013-30.

32. Paller AS, Siefried EC, Langley RG, et al. Etanercept treatment for children and adolescent with plaque psoriasis. N Engl J Med 2008 Jan 17;358(3):241-51.